Skip to main content

BOOTHBAY FUND MANAGEMENT, LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1549230 NEW YORK, NY

Position in TEVA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$2,661,975
-$890,128 QoQ
Shares Held
88,379
-22.3% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
10 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Derivatives in TEVA

reported options exposure · as of Mar 31, 2026
CallValue
$1,256,004
CallShares
41,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $50,237,325 across 12 Drug Manufacturers - Specialty & Generic names. TEVA ranks #6 (5.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 TEVA
Teva Pharmaceutical Industries Ltd
This page
88,379 $2,661,975

All Filings in TEVA

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,256,004 41,700
2026-03-31 $2,661,975 88,379
2025-12-31 $3,552,103 113,813
2025-09-30 $1,183,720 58,600
2025-09-30 $4,033,010 199,654
2025-06-30 $3,053,135 182,168
2025-06-30 $982,136 58,600
2025-03-31 $900,682 58,600
2024-12-31 $636,956 28,900
2022-06-30 $1,517,618 201,811
2022-03-31 $859,635 91,548
2021-12-31 $632,085 78,912
2020-03-31 $257,726 28,700